oral semaglutide news improves blood sugar, weight, and liver markers in real-world diabetes care AgelessRx Adds Oral GLP-1 Drops

Medicaid coverage for obesity treatment varies dramatically by state

But they are not the same drug, and the differences between them are now clearer than ever thanks to the landmark SURMOUNT-5 head-to-head clinical trial , the first study to compare them directly in the same patient population

Two key mechanisms include: Melanin Stimulation: The peptide activates melanocytes (the skins pigment-producing cells), encouraging the body to develop a natural tan with less UV exposure

While some findings suggest mild effects, reports of nausea, pigmentation changes, and altered moles highlight important risks

Carpal tunnel-style symptoms, including tingling or numbness in the hands, are commonly interpreted as a sign of excessive GH/IGF-1 exposure in community protocols, prompting a dose reduction or pause consult a clinician

5-Amino-1MQ (10 mg): the NNMT inhibitor that isn't a peptide 5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of NNMT